China Universal Asset Management Company’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Buy
15,668
+1,842
+13% +$14K 0.01% 373
2026
Q1
$99.5K Buy
13,826
+1,131
+9% +$7.27K 0.01% 403
2025
Q4
$71.6K Sell
12,695
-954
-7% -$5.17K 0.01% 430
2025
Q3
$84.2K Sell
13,649
-1,920
-12% -$11.2K 0.01% 403
2025
Q2
$75.8K Buy
15,569
+261
+2% +$923 0.01% 387
2025
Q1
$56.6K Buy
15,308
+6,836
+81% +$29.3K 0.01% 412
2024
Q4
$33.9K Buy
+8,472
New +$46.5K ﹤0.01% 470
2022
Q4
Sell
-71
Closed 457
2022
Q3
$0 Buy
+71
New +$716 ﹤0.01% 458

Other funds holding SLDB

China Universal Asset Management Company's SLDB Position: Q2 2026 in Review

China Universal Asset Management Company increased its Solid Biosciences (SLDB) stake by 13% in Q2 2026, buying an estimated $14K and bringing the position to 15,668 shares worth $157K. The position accounts for 0.01% of the portfolio, ranked #373.

China Universal Asset Management Company first reported a position in SLDB in Q3 2022 and has held it in 8 quarters since. 19 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • China Universal Asset Management Company held 15,668 shares of Solid Biosciences worth $157K as of Q2 2026.
  • China Universal Asset Management Company bought 1,842 Solid Biosciences shares in Q2 2026, an estimated $14K.
  • Solid Biosciences made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #373 holding.
  • China Universal Asset Management Company first reported a position in Solid Biosciences in Q3 2022 and has held it in 8 quarters since.
  • 19 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.